Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial
Reported by Smithsonian Magazine ·
Smithsonian Magazine reports: "Experimental Alzheimer's Drug That Fights a Tough-to-Target Protein Shows Promise at Slowing Cognitive Decline in a Clinical Trial". It explores practical choices and cultural shifts in sustainable living. Read the full story at Smithsonian Magazine for complete details.
Read the full story at Smithsonian Magazine ↗P x BC News curates sustainability journalism. The reporting above belongs to Smithsonian Magazine; the summary is our own. We always link to the original.
Related coverage
- Development
The brain-body connection is key to reducing the risk of cognitive decline and Alzheimer’s disease
Caribbean News Global
- Lifestyle
Fossil Footprints in Brazil Hint at a Cougar-Size Mammal That Walked Among Dinosaurs. It's Another Sign That Some Early Beasts Grew to Impressive Sizes After All
Smithsonian Magazine
- Lifestyle
‘This is a robust recipe’: the experimental farm bucking the decline in UK birds
The Guardian
- Lifestyle
Legend Has It That This Roman Emperor Established a Camp in Wales. A Newly Discovered Fort May Offer Proof That It Really Existed
Smithsonian Magazine